FDA Adverse Event Injury Summary report: N

VERSAFITCUP CC TRIO ACETABULAR SHELL Ø 56

MDR report key: 5685307 · Received May 27, 2016

Report

Report Number
3005180920-2016-00249
Event Type
Injury
Date Received
May 27, 2016
Date of Event
April 29, 2016
Report Date
August 4, 2016
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
LZO
PMA / PMN Number
K103352
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ON 28JULY 2016 IT WAS PREPARED A FINAL REPORT WITH THE INFORMATION ALREADY REPORTED IN THE INITIAL REPORT. ON 02 AUGUST 2016 IT WAS SENT TO THE INITIAL REPORTER AND THE CASE WAS CLOSED.

Additional Manufacturer Narrative · 1

ON 20 MAY 2016 CERAMTEC PROVIDED A DOCUMENT REVIEW OF THE NON-MEDACTA PRODUCT - CERAMIC LINER - INVOLVED IN THIS COMPLAINT IN WHICH NO ANOMALIES HAVE BEEN DETECTED. BATCH REVIEWS PERFORMED ON 27 MAY 2016. LOT 124699: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 15 JANUARY 2013. EXPIRATION DATE: 2017-12-31. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL ITEMS OF THIS LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT. QUADRA-H, CEMENTLESS, HA COATED STEM SIZE 5 STD, CODE 01.12.025, LOT. 123628 (K082792). (B)(4) ITEMS MANUFACTURED AND RELEASED ON 21 NOVEMBER 2012. EXPIRATION DATE: 2017-10-31. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL ITEMS OF THIS LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT. VERSAFITCUP FLAT PE LINER Ø 32 / F, CODE 01.26.3248STT, LOT. 125464 (K103352). (B)(4) ITEMS MANUFACTURED AND RELEASED ON 01 MARCH 2013. EXPIRATION DATE: 2018-01-31. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT.

Description of Event or Problem · 1

REVISION PLANNED DUE TO A SUSPICION OF INFECTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
339060 VERSAFITCUP CC TRIO ACETABULAR SHELL Ø 56 ACETABULAR SHELL LZO MEDACTA INTERNATIONAL SA 124699

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention